A detailed history of California State Teachers Retirement System transactions in Aerovate Therapeutics, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 977 shares of AVTE stock, worth $2,501. This represents 0.0% of its overall portfolio holdings.

Number of Shares
977
Previous 977 -0.0%
Holding current value
$2,501
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.41 - $30.75 $207 - $4,520
-147 Reduced 13.08%
977 $1,000
Q1 2024

May 15, 2024

SELL
$17.68 - $29.57 $12,658 - $21,172
-716 Reduced 38.91%
1,124 $33,000
Q4 2023

Feb 13, 2024

SELL
$9.58 - $24.25 $87,867 - $222,421
-9,172 Reduced 83.29%
1,840 $41,000
Q3 2023

Nov 14, 2023

BUY
$12.9 - $18.88 $14,396 - $21,070
1,116 Added 11.28%
11,012 $149,000
Q2 2023

Aug 21, 2023

SELL
$15.63 - $22.01 $16,614 - $23,396
-1,063 Reduced 9.7%
9,896 $169,000
Q1 2023

May 09, 2023

SELL
$19.17 - $27.7 $2,338 - $3,379
-122 Reduced 1.1%
10,959 $221,000
Q4 2022

Feb 14, 2023

BUY
$15.92 - $30.52 $118,699 - $227,557
7,456 Added 205.68%
11,081 $324,000
Q3 2022

Nov 18, 2022

SELL
$14.77 - $25.79 $4,460 - $7,788
-302 Reduced 7.69%
3,625 $60,000
Q2 2022

Aug 15, 2022

SELL
$10.8 - $16.91 $18,090 - $28,324
-1,675 Reduced 29.9%
3,927 $61,000
Q1 2022

May 16, 2022

SELL
$8.25 - $18.33 $2,640 - $5,865
-320 Reduced 5.4%
5,602 $103,000
Q4 2021

Feb 15, 2022

BUY
$9.14 - $21.54 $4,359 - $10,274
477 Added 8.76%
5,922 $70,000
Q3 2021

Nov 15, 2021

BUY
$11.76 - $22.49 $64,033 - $122,458
5,445 New
5,445 $114,000

Others Institutions Holding AVTE

About Aerovate Therapeutics, Inc.


  • Ticker AVTE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,448,100
  • Market Cap $62.6M
  • Description
  • Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...
More about AVTE
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.